These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733 [TBL] [Abstract][Full Text] [Related]
8. Effect of ketorolac on Candida albicans ocular infection in rabbits. Fraser-Smith EB; Matthews TR Arch Ophthalmol; 1987 Feb; 105(2):264-7. PubMed ID: 3492994 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Stewart R; Grosserode R; Cheetham JK; Rosenthal A Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737 [TBL] [Abstract][Full Text] [Related]
10. Effect of ketorolac on herpes simplex virus type one ocular infection in rabbits. Fraser-Smith EB; Matthews TR J Ocul Pharmacol; 1988; 4(4):321-6. PubMed ID: 3246566 [TBL] [Abstract][Full Text] [Related]
11. Ketorolac tromethamine in the maintenance of intraoperative mydriasis. Gupta VP; Dhaliwal U; Prasad N Ophthalmic Surg Lasers; 1997 Sep; 28(9):731-8. PubMed ID: 9304635 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Flach AJ; Dolan BJ; Irvine AR Am J Ophthalmol; 1987 Apr; 103(4):479-86. PubMed ID: 3551617 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. Sandoval HP; De Castro LE; Vroman DT; Solomon KD J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191 [TBL] [Abstract][Full Text] [Related]
15. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis. Rabiah PK; Fiscella RG; Tessler HH Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961 [TBL] [Abstract][Full Text] [Related]
16. The effect of flurbiprofen 0.03% eye drops on the blood aqueous barrier in extracapsular cataract extraction with IOL implantation. Diestelhorst M; Aspacher F; Konen W; Krieglstein GK Int Ophthalmol; 1991 Mar; 15(2):69-73. PubMed ID: 2022441 [TBL] [Abstract][Full Text] [Related]
17. Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study. Diestelhorst M; Aspacher F; Konen W; Krieglstein GK; Hilgers RD Graefes Arch Clin Exp Ophthalmol; 1992; 230(5):451-3. PubMed ID: 1521812 [TBL] [Abstract][Full Text] [Related]
18. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain. O'Hara DA; Fragen RJ; Kinzer M; Pemberton D Clin Pharmacol Ther; 1987 May; 41(5):556-61. PubMed ID: 3568540 [TBL] [Abstract][Full Text] [Related]
19. Ocular bioavailability and tissue distribution of [14C]ketorolac tromethamine in rabbits. Ling TL; Combs DL J Pharm Sci; 1987 Apr; 76(4):289-94. PubMed ID: 3598886 [TBL] [Abstract][Full Text] [Related]
20. Steroidal and nonsteroidal anti-inflammatory agents. Effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Sanders DR; Kraff M Arch Ophthalmol; 1984 Oct; 102(10):1453-6. PubMed ID: 6385931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]